Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
In order to determine whether branched-chain ketoacids can reduce the excessive rate of muscle protein degradation that characterizes Duchenne muscular dystrophy, nine boys affected with the disease were studied in a metabolic ward while receiving meat-free diets. After a three-day equilibration period, excretion rates of 3-methylhistidine and creatinine were measured in two consecutive four-day periods. In the second period, a supplement containing a mixture of ornithine alpha-ketoisocaproate, alpha-ketoisovalerate, and alpha-keto-beta-methylvalerate in a proportion of 4:1:1 was administered orally at a dosage of 0.45 gm/kg/day. During treatment with the ketoacids, 3-methylhistidine excretion fell by a small (mean: 14%) but highly significant (P less than 0.01) extent, whether expressed in absolute terms or in relation to creatinine excretion. No adverse effects were noted. We conclude that this mixture of ketoacids acutely reduces muscle protein degradation in patients with Duchenne muscular dystrophy.
D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000652:urine; D006801:Humans; D007651:Keto Acids / Q000627:therapeutic use*; D008297:Male; D008762:Methylhistidines / Q000652:urine; D009124:Muscle Proteins / Q000378:metabolism*; D009136:Muscular Dystrophies / Q000188:drug therapy* / Q000378:metabolism; D009584:Nitrogen / Q000652:urine
D007651:Keto Acids; D008762:Methylhistidines; D009124:Muscle Proteins; D003404:Creatinine; D009584:Nitrogen